242 related articles for article (PubMed ID: 32094357)
1. Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration.
Gomez-Acevedo H; Dai Y; Strub G; Shawber C; Wu JK; Richter GT
Sci Rep; 2020 Feb; 10(1):3261. PubMed ID: 32094357
[TBL] [Abstract][Full Text] [Related]
2. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
3. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
4. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of periorbital infantile hemangiomas: Case series and literature review.
Sun LM; Xu Y; Xu MN; Wang M; Su Y; Yuan SM
Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110157. PubMed ID: 32544638
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers for hemangiomas.
Gelmetti C; Cavalli R
G Ital Dermatol Venereol; 2014 Dec; 149(6):703-9. PubMed ID: 25366892
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.
Tang YJ; Zhang ZZ; Chen SQ; Chen SM; Li CJ; Chen JW; Yuan B; Xia Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):759-762. PubMed ID: 26489635
[TBL] [Abstract][Full Text] [Related]
9. Propranolol versus corticosteroids: what should be the treatment of choice in infantile hemangiomas?
Theunissen CI; Smitt JH; van der Horst CM
Ann Plast Surg; 2015 Feb; 74(2):237-41. PubMed ID: 24051459
[TBL] [Abstract][Full Text] [Related]
10. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
11. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment.
Wnęk A; Andrzejewska E; Kobos J; Taran K; Przewratil P
Immunol Lett; 2017 May; 185():27-31. PubMed ID: 28279700
[TBL] [Abstract][Full Text] [Related]
12. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
[TBL] [Abstract][Full Text] [Related]
13. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
Li P; Guo Z; Gao Y; Pan W
Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
[TBL] [Abstract][Full Text] [Related]
14. [Effect of propranolol gel on infantile hemangiomas].
Zhai YN; Song HT; Chen SQ; Zhang MX; Li CJ; Xia Y; Wang L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jan; 29(1):25-8. PubMed ID: 23600126
[TBL] [Abstract][Full Text] [Related]
15. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
16. Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.
Mong EF; Akat KM; Canfield J; Lockhart J; VanWye J; Matar A; Tsibris JCM; Wu JK; Tuschl T; Totary-Jain H
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1321-1332. PubMed ID: 29724816
[TBL] [Abstract][Full Text] [Related]
17. Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children.
Al Dhaybi R; Superstein R; Milet A; Powell J; Dubois J; McCuaig C; Codère F; Hatami A; Chevrette L; Fallaha N; Hamel P; Ospina LH
Ophthalmology; 2011 Jun; 118(6):1184-8. PubMed ID: 21292326
[TBL] [Abstract][Full Text] [Related]
18. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
[TBL] [Abstract][Full Text] [Related]
19. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
20. Serum apelin as a potential biomarker for infantile hemangiomas.
Chen Q; Zhang Y; Ni S; Yang L; Li J; Yuan X; Chen M; Liu J; Luo X; Xie Y; Wang H
Pediatr Blood Cancer; 2024 Jul; 71(7):e30989. PubMed ID: 38602300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]